Daniel Landsburg Selected Research

CTL019 chimeric antigen receptor

12/2018

Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Landsburg Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 12/2017
4	Lymphoma (Lymphomas) 01/2019 - 08/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2018
2	Sepsis (Septicemia) 07/2019 - 01/2019
2	Fever (Fevers) 07/2019 - 01/2019
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2019 - 08/2014
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2018 - 12/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 12/2017
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Anemia 01/2022
1	Febrile Neutropenia 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2020
1	Hemorrhage 11/2019
1	Diarrhea 07/2019
1	Clostridium Infections 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2019
1	Cytokine Release Syndrome 12/2018
1	Inflammation (Inflammations) 12/2018
1	Mycosis Fungoides 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Pathologic Complete Response 12/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2017
1	Progressive Multifocal Leukoencephalopathy 08/2014

Drug/Important Bio-Agent (IBA)

4	Chimeric Antigen ReceptorsIBA 01/2022 - 12/2017
3	tisagenlecleucelIBA 11/2020 - 12/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2020
2	Levofloxacin (Levaquin)FDA Link 07/2019 - 01/2019
2	Brentuximab VedotinIBA 01/2018 - 08/2014
1	serum P-component (CIt)IBA 01/2022
1	Proton Pump InhibitorsIBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2019
1	beta-LactamsIBA 07/2019
1	FluoroquinolonesIBA 01/2019
1	Bexarotene (LGD1069)FDA Link 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	CTL019 chimeric antigen receptorIBA 12/2018
1	ibrutinibIBA 01/2018
1	EnzymesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 12/2017
1	Immunoglobulin M (IgM)IBA 12/2017
1	Immunoglobulin A (IgA)IBA 12/2017
1	Monoclonal AntibodiesIBA 08/2014
1	Pharmaceutical PreparationsIBA 08/2014

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2022 - 08/2014
3	Therapeutics 01/2019 - 08/2014
1	Immunotherapy 12/2018
1	Transplantation 12/2017